Schneiderman Daniel H 4
4 · Pasithea Therapeutics Corp. · Filed Mar 1, 2024
Insider Transaction Report
Form 4
Schneiderman Daniel H
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2024-03-01+10,000→ 10,000 totalExercise: $8.34Exp: 2034-02-28→ Common Stock (10,000 underlying) - Award
Stock Option (right to buy)
2024-03-01+5,927→ 5,927 totalExercise: $8.34Exp: 2034-02-28→ Common Stock (5,927 underlying)
Footnotes (2)
- [F1]The option award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan (the "2023 Plan"). The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the option award will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting date.
- [F2]The option award was made in accordance with the terms of the 2023 Plan. The option award fully vested upon issuance and became exercisable on March 1, 2024.